Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Walkers advised FinAccel on the transaction. Also White & Case worked on the deal. Latham & Watkins represented the placement agents in the...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Walkers Singapore advised FinAccel on the deal. FinAccel, the parent of artificial intelligence-enabled digital consumer credit platform Kredivo, announced its agreement to merge with...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Zoom Video Communications, while Latham & Watkins LLP represented Five9 on the deal. Zoom Video Communications has entered into a definitive agreement to acquire Five9,...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Ethos on the deal. Ethos, an insurtech company that’s transforming the life insurance space, announced its $200 million Series D financing round, which brings...
You must be a Standard 1 Year member to access this content.
